181 related articles for article (PubMed ID: 16247484)
1. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.
Koinuma K; Yamashita Y; Liu W; Hatanaka H; Kurashina K; Wada T; Takada S; Kaneda R; Choi YL; Fujiwara SI; Miyakura Y; Nagai H; Mano H
Oncogene; 2006 Jan; 25(1):139-46. PubMed ID: 16247484
[TBL] [Abstract][Full Text] [Related]
2. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
3. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
4. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
6. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
7. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.
Dykes SL; Qui H; Rothenberger DA; García-Aguilar J
Cancer; 2003 Jul; 98(1):48-54. PubMed ID: 12833454
[TBL] [Abstract][Full Text] [Related]
9. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
12. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
[TBL] [Abstract][Full Text] [Related]
13. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
14. Pathways of colorectal carcinogenesis.
Arends MJ
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):97-102. PubMed ID: 23417071
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
18. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.
Muto Y; Maeda T; Suzuki K; Kato T; Watanabe F; Kamiyama H; Saito M; Koizumi K; Miyaki Y; Konishi F; Alonso S; Perucho M; Rikiyama T
BMC Cancer; 2014 Jun; 14():466. PubMed ID: 24964857
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
